Smart Insulin Pens for Diabetes Management
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 50 (estimated)
- Sponsor
- University of Maryland, Baltimore · Other
This trial is looking for adults with diabetes who are using multiple daily insulin injections. Participants will use Smart Insulin pens and telemedicine to see if this improves their blood sugar control compared to traditional methods.
You may be able to join if
- I am at least 18 years old
- I have been using multiple daily insulin injections for at least 3 months
You may not be able to join if
- I am not using multiple daily insulin injections
- I am using an insulin pump
- I am pregnant
- I have significant skin issues that prevent me from wearing a sensor
- I have end-stage renal disease requiring dialysis
- I have a serious psychiatric condition that affects my understanding
- I have started new non-insulin diabetes medications or changed my dose in the last 60 days
- I do not have access to a compatible smartphone
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityAlmost 40% of veterans have diabetes, the proposed research may improve clinical care among veterans with diabetes. In this application we are going to examine whether utilizing Smart Insulin pens (SIPs) with CGMs and telemedicine is a better tool for managing diabetes compared to traditional insulin pens, CGMs and telemedicine, leading to improved blood sugar control and better clinical outcomes.
Loading trial locations…